Your Messages Inbox
Your Article Summary
See Latest ArticlesImmunoGen, Inc. Appoints Peter Williams as Vice President, Business Development
ImmunoGen, Inc., 08/18/09
ImmunoGen, Inc. , a biopharmaceutical company that develops targeted anticancer therapeutics, today announced the appointment of Peter Williams as Vice President, Business Development.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Bristol-Myers Squibb Sets Exchange Ratio of 0.6313 for the Exchange Offer
Bristol Myers-Squibb Company, 12/17/09
Abbott Declares 344th Consecutive Quarterly Dividend
Abbott, 12/15/09
Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering
Dendreon Coproration, 12/15/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
deCODE Discovers A Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin
deCODE genetics, 12/17/09
The Medtronic Foundation Offers Grants to Schools Participating in Online Sudden Cardiac Arrest Response Training
Medtronic, 12/17/09
AstraZeneca and the University of Virginia sign strategic research collaboration to develop novel treatments for cardiovascular disease
AstraZeneca, 12/16/09
Article Search
Sponsor